CMS to modify, not withdraw Part B proposal

On Tuesday, acting CMS Deputy Administrator Patrick Conway deflected withering bipartisan criticism from U.S. Senate Finance Committee members of the agency's planned value-based Part B drug purchasing project. When asked directly if CMS plans to withdraw the proposed rule, Conway said

Read the full 410 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE